COMMITTEE II - CARDIOVASCULAR & RESPIRATORY ......2 COMMITTEE II - CARDIOVASCULAR & RESPIRATORY SYSTEMS LECTURERS MED 302 INTRODUCTION to CLINICAL SCIENCES DISCIPLINE LECTURERS PHARMACOLOGY

1

COMMITTEE II - CARDIOVASCULAR & RESPIRATORY SYSTEMS

DISTRIBUTION of LECTURE HOURS November 23, 2020 –January 8, 2021 COMMITTEE DURATION: 7 WEEKS

MED 302

INTRODUCTION to CLINICAL SCIENCES

ABB. THEO. PRAC. LAB/CSL DISCUSSION TOTAL

DIS

CIP

LIN

E

PHARMACOLOGY PC 25 25

PATHOLOGY PT 24 1x3=3

(2 Groups) 27

CHEST MEDICINE CHM 18 18

CARDIOLOGY CRD 14 14

PUBLIC HEALTH PH 8 8

PATHOPHYSIOLOGY PP 7 7

INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY

IDCM 5 5

BIOMEDICAL ETHICS & DEONTOLOGY

BED 4 4

ENT DISEASES ENT 4 4

BIOISTATISTICS BS 3 3

THORACIC SURGERY TS 3 3

FAMILY MEDICINE FM 4 4

PEDIATRICS PED 2 2

MEDICAL GENETICS MG 2 2

EMERGENCY MEDICINE EM 2 2

IMMUNOLOGY IMM 2 2

RADIOLOGY RAD 1 1

INTERDISCIPLINARY MCDP 2 2

TOTAL 128 3 2 133

OTHER COURSES

SCIENTIFIC RESEARCH and PROJECT COURSE-III

SRPC 2x2=4

(4 Groups) 4

MED 303

INTRODUCTION to CLINICAL PRACTICE III

ICP III 2x3=6

(4 Groups) 6

TOTAL 128 3 6 6 143

INDEPENDENT LEARNING 98

Coordination Committee

HEAD Ferda Özkan, MD, Prof.

SECRETARY Banu Musaffa Salepçi, MD, Prof.

MEMBER Müzeyyen Doğan, MD, Assoc. Prof.

MEMBER Mustafa Aytek Şimşek, MD, Assist. Prof.

MEMBER Emine Nur Özdamar, MD, Assist. Prof.

2

COMMITTEE II - CARDIOVASCULAR & RESPIRATORY SYSTEMS

LECTURERS

MED 302 INTRODUCTION to CLINICAL SCIENCES

DISCIPLINE LECTURERS

PHARMACOLOGY Ece Genç, PhD, Prof. Emine Nur Özdamar, MD, Asst. Prof.

PATHOLOGY Aydın Sav, MD, Prof. Ferda Özkan, MD, Prof.

CHEST MEDICINE Banu Musaffa Salepçi, MD, Prof. Seha Akduman, MD

CARDIOLOGY

Muzaffer Değertekin, MD, Prof. Olcay Özveren, MD, Assoc. Prof. Kartal Emre Aslanger MD, Assoc. Prof. AyçaTürer Cabbar, MD, Assist. Prof. Mustafa Aytek Şimşek, MD, Assist. Prof. Burak Hünük ,MD, Assist. Prof.

PUBLIC HEALTH Recep Erol Sezer, MD, Prof. Hale Arık Taşyıkan, MD, Assist. Prof.

BIOMEDICAL ETHICS & DEONTOLOGY

Elif Vatanoğlu Lutz, MD, Assoc. Prof.

PATHOPHYSIOLOGY Mehtap Kaçar, MD, Assoc. Prof.

INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY

Meral Sönmezoğlu, MD, Prof. A. Çağrı Büke, MD, Prof

EAR- NOSE -THROAT (ENT) Arzu Tatlıpınar, MD, Prof. Müzeyyen Doğan, MD, Assoc. Prof.

THORACIC SURGERY Sina Ercan, MD, Prof.

FAMILY MEDICINE Güldal İzbırak, MD, Assoc.Prof. Özlem Tanrıöver, MD, Prof.

PEDIATRICS Hülya Sarıçoban, MD, Assoc. Prof. Fatma Tuba Coşkun, MD

MEDICAL GENETICS Ayşegül Çınar Kuşkucu, MD, Asst. Prof.

RADIOLOGY Filiz Çelebi, MD.

EMERGENCY MEDICINE Merve Ekşioğlu, MD. Mustafa Yazıcıoğlu, MD, Assist. Prof.

BIOSTATISTICS Çiğdem Altunok, PhD, Assist. Prof

IMMUNOLOGY Gülderen Yanıkkaya Demirel, MD, Phd, Prof.

OTHER COURSES


SCIENTIFIC RESEARCH and PROJECT COURSE-III

Bayram Yılmaz, PhD, Prof. Hale Arık Taşyıkan, MD, Assist Prof.

MED 303 INTRODUCTION to CLINICAL PRACTICE III


CLINICAL SKILLS LAB

Ferdi Menda MD, Prof. Banu Musaffa Salepçi, MD, Prof. Seha Akduman, MD Olcay Özveren, MD, Assoc. Prof. Ayça Türer Cabbar, MD, Assist. Prof. Mustafa Aytek Şimşek, MD, Assist. Prof. Nurcan Kızılcık, MD, Assist. Prof. Tuğhan Utku, MD, Assoc. Prof.

3

COMMITTEE II - CARDIOVASCULAR and RESPIRATORY SYSTEMS

AIMS and LEARNING OBJECTIVES

AIMS

In evidence based manner,

1. to remind knowledge on anatomy, histology and physiology of cardiovascular and respiratory

systems,

2. to convey knowledge on etiopathogenesis of clinical conditions which are frequent in

community and/or pose high risk for individual or community health, and/or life-threatening or

constitute an emergency related to cardiovascular and respiratory systems,

3. to convey knowledge on epidemiology of clinical conditions which are frequent in community

and/or pose high risk for individual or community health, and/or life-threatening or constitute

an emergency related to cardiovascular and respiratory systems,

4. to convey necessary knowledge on prevention of clinical conditions, and protection or

improvement of health against those clinical conditions related to cardiovascular and

respiratory systems,

5. to convey knowledge on mechanisms of occurrence for frequently encountered clinical

complaints, symptoms, signs and findings in clinical conditions which are frequent in

community and/or pose high risk for individual or community health, and/or life-threatening or

constitute an emergency related to cardiovascular and respiratory systems,

6. to convey necessary knowledge together with performance measures on health care

processes, clinical decision making process, clinical decisions and clinical practices required

for managing clinical conditions related to cardiovascular and respiratory systems, which are

frequent in community and/or pose high risk for individual or community health, and/or life-

threatening or constitute an emergency, at the level of primary health care service,

7. to convey knowledge on principles of prescription,

8. to convey necessary knowledge on pharmacology of drugs effective on cardiovascular

system,

9. to convey necessary knowledge on radiation physics and biology and its use in oncology,

10. to convey necessary knowledge on ethical problems encountered in health care service and

utilization, and on principles of solutions,

11. to convey knowledge on principles of biostatistical analysis,

12. to equip with basic and advanced clinical skills (advanced cardiac life support-C2,

approach to patient with cardiovascular clinical condition-C2) required at primary health care

service level.

LEARNING OBJECTIVES

At the end of this committee, student should be able to:

1.0.recall anatomy, histology and physiology of cardiovascular and respiratory systems,

2.0.explain etiopathogenesis of clinical conditions (upper respiratory tract problems, nasal obstruction,

etc.-, infectious clinical conditions with upper and lower respiratory tract and lung involvement -

pneumonia, tuberculosis, etc., circulatory lung disorders -pulmonary embolism, etc.-,

obstructive/restrictive lung diseases, respiratory insuffiency, tobacco use, lung tumors,other lung

diseases; diseases of coronary circulation and coronary arteries, diseases of cardiac valves,

myocardial and pericardial diseases, blood stream infections and sepsis, cardiac problems in

adults and children, mediastinal diseases, nasopharyngeal and oropharyngeal diseases, nasal and

paranasal sinus diseases, diseases of middle ear and eustachian tube, laryngeal diseases, voice

disorders) which are frequent in community and/or pose high risk for individual or community

health, and/or life-threatening or constitute an emergency related to cardiovascular and respiratory

systems,

4

3.0.explain epidemiology of clinical conditions which are frequent in community and/or pose high risk

for individual or community health, and/or life-threatening or constitute an emergency related to

cardiovascular and respiratory systems,

4.0.explain prevention of clinical conditions, and protection or improvement of health against those

clinical conditions related to cardiovascular and respiratory systems,

5.0.describe mechanisms of occurrence for frequently encountered clinical complaints, symptoms,

signs and findings in clinical conditions which are frequent in community and/or pose high risk for

individual or community health, and/or life-threatening or constitute an emergency related to

cardiovascular and respiratory systems,

6.0.at multi-system level and/or related to cardiovascular and respiratory systems,

for healthy conditions in an individual or community with a request against clinical

conditions that pose risks,

in an individual with clinical complaint, symptom, sign or laboratory/imaging finding or in a

community,

for clinical conditions which are frequent in community and/or pose high risk for individual

or community health, and/or life-threatening or constitute an emergency,

explain in an evidence-based manner and together with performance measures from the aspects

of reliability, practicality and outcomes, health care processes, clinical decision making process,

clinical decisions and clinical practices

which are required for management at primary health care service level:

6.1. practice of history taking and physical examination (cardiovascular, pulmonary)

6.2. evaluation of emergency case (dyspnea)

6.3. approach to healthy individual or patient (cardiovascular disease, chest pain, cough and

hemoptysis, dyspnea)

6.4. laboratory tests/examinations (cardiac markers-, coagulation tests-, blood gases-, pulmonary

function tests)

6.5. imaging tests/examinations (radionuclide ventriculography, myocardial scintigraphy, cardiac PET,

ventilation/perfusion scintigraphyi, PET in lung cancer)

6.6. point of care testing (urine strip/dipstick test)

6.7. making preliminary diagnosis or definitive diagnosis decision

6.8. making non-intervention or intervention decision

6.9. practicing non-intervention or intervention

6.10. referral/transport of healthy individual or patient

7.0.define radiation physics, biology and its use in oncology,

8.0.explain implementation of hypertension treatment guidelines,

9.0.explain pharmacology of drugs effective on cardiovascular system (autonomic system

pharmacology, renin-angiotensin system pharmacology, calcium channel blockers,

pharmacological approach to ischemic and congestive cardiovascular conditions, drugs effecting

body fluids and volume, anti-hypertension drugs, hypolipidemic drugs, antiarrhythmic drugs,

antiplatelet, antithrombotic and thrombolytic drugs, drugs used in the treatment of asthma and

chronic obstructive pulmonary disease, antitussive, expectorant and surfactant drugs),

10.0 explain genetics of cardiovascular and respiratory system,

11.0.explain ethical problems (rejection of treatment, organ transplantation, paternalism, reproductive

and negative rights),

12.0.explain principles of biostatistical analysis,

13.0.perform basic clinical skills, practiced on phantom models (advanced cardiac life support), and

advanced clinical skills, practiced on simulated/standardized patients (approach to patient with

cardiovascular clinical condition), required at primary health care service.

5


COMMITTEE ASSESSMENT MATRIX PHASE III

COURSE: MED 302 INTRODUCTION to CLINICAL SCIENCES COURSE COMPONENT: COMMITTEE II - CARDIOVASCULAR & RESPIRATORY SYSTEMS

QUESTION DISTRIBUTION TABLE

LEARNING OBJECTIVE DISCIPLINE LECTURER/ INSTRUCTOR

NUMBER of QUESTIONS

(MCQ)

CE FE IE Total

8.0.,9.0 PC E. Genç

17 8 8 33 E. N. Özdamar

1.0.,2.0 PT F. Özkan

17 7 7 31 A. Sav

1.0.,2.0.,5.0.,6.0-6.10 CHM S. Akduman

12 6 6 24 B. Salepçi

1.0.,2.0.,5.0.,6.0-6.10 CRD

M.Degertekin

11 4 4 19

O. Özveren

K. E Aslanger

A. Cabbar

B. Hünük

M.A. Şimşek

3.0.,4.0 PH R.E. Sezer

6 2 2 10 H.A.Taşyıkan

2.0.,5.0 PP M. Kaçar 5 2 2 9

2.0.,5.0.,6.0, 6,4 IDCM M. Sönmezoğlu

3 2 2 7 A.Ç. Büke

11.0 BED E. Vatanoğlu Lutz 3 1 1 5

1.0.,2.0.,5.0.,6.0 ENT M. Doğan

3 1 1 5 A. Tatlıpınar

12.0 BS Ç. Altunok 2 1 1 4

6.3 TS S. Ercan 2 1 1 4

1.0.,2.0.,5.0.,6.0, 6.10 FM G.Izbırak

2 1 1 4 Ö. Tanrıöver

2.0.,5.0, 6.3 PED H. Sarıçoban

2 1 1 4 T. Coşkun

10.0 MG A.Ç. Kuşkucu 2 1 1 4

6.2 EM M. Ekşioğlu

1 1 1 3 M. Yazıcıoğlu

2.0.,5.0 IMM G.Y. Demirel 1 1 1 3

6.5 RAD F. Çelebi 1 0 0 1

TOTAL 90 40 40 170

LEARNING OBJECTIVE FACULTY

DEPARTMENT LECTURER/INSTRUCTOR

NUMBER of QUESTIONS

(EMQ)

CE FE IE Total

1.0.,2.0.,5.0.,6.0-6.10 CHM B. Salepçi 1 - - 1

1.0.,2.0 PT F. Özkan 2 - - 2

8.0.,9.0 CRD M. Değertekin 2 - - 2

TOTAL 5 - - 5

CS*= 90 pts (MCQ) + 10 pts (EMQ) = 100 pts; pts:points

*Each MCQ has a value of 1 points; each EMQ question has a value of 2 points.

Abbreviations

MCQ: Multiple Choice Question

EMQ: Extending Matching Question

CE: Committee Exam

CS: Committee Score

FE: Final Exam

ICE: Incomplete Exam

**41 out of 200 FE and ICE MCQs will be from Committee II (Each question is of worth 0.5 pts).

6

COMMITTEE II - CARDIOVASCULAR and RESPIRATORY SYSTEMS WEEK I / 23 - 27 Nov 2020

Monday

23-Nov-2020 Tuesday

24-Nov-2020 Wednesday 25-Nov-2020

Thursday 26-Nov-2020

Friday 27-Nov-2020

09.00- 09.50 Independent Learning

Lecture General Signs and Principal Symptoms in Cardiovascular

System Diseases K. E. Aslanger

Coronary Artery Disease I M. Değertekin

ICP-CSL (Advanced Cardiac Life

Support) F. Menda / N. Kızılcık /

T. Utku

Independent Learning

10.00- 10.50

Independent Learning Lecture

Examination of the Heart K. E. Aslanger

Lecture Coronary Artery Disease II

M. Değertekin

Gro

up

A

Sm

all G

rou

p S

tud

y

SR

PC

Gro

up

B I

CP

Gro

up

C IL

Gro

up

D IL


11.00- 11.50


Hypertension M. A. Şimşek

Lecture Acetylcholinesterase

Inhibitors E. Genç

Lecture How to Write a Project Report?

B. Yılmaz / H. Taşyıkan

12.00- 12.50

Independent Learning Lecture Pericardial Diseases

M. A. Şimşek

Lecture Acetylcholine and Directly

Acting Parasympathomimetic Drugs

E. Genç


Lecture Scientific Career and Preparation of

CV B. Yılmaz / H. Taşyıkan

12.50 - 14.00 LUNCH BREAK

14.00- 14.50

Lecture Hypertension Treatment

Guidelines E. N. Özdamar

Lecture Pathophysiology of Cardiovascular

System Disorders I M. Kaçar


Lecture Parasympatholitic Drugs

E. Genç

ICP-CSL (Advanced Cardiac Life Support) F. Menda / N. Kızılcık / T. Utku

15.00- 15.50 Lecture

Anti-hypertensive Drugs I E. N. Özdamar


System Disorders II M. Kaçar


Lecture Sympathomimetic Drugs:

Catecholamines & Noncatecholamines

E. Genç

Gro

up

A

ICP

Gro

up

B

Sm

all G

rou

p S

tud

y

SR

PC

Gro

up

C IL

Gro

up

D IL

16.00- 16.50 Lecture

Anti-hypertensive Drugs II E. N. Özdamar


System Disorders III M. Kaçar



17.00-17.50 Independent Learning

Lecture Introduction to Autonomic System

Pharmacology E. Genç


Independent Learning Independent Learning

IL: Independent Learning, CSL: Clinical Skills Learning, YH: Yeditepe University Hospital. Student groups for laboratory/practice sessions will be announced by coordinators.

7


WEEK II / 30 Nov-4 Dec 2020

Monday

30-Nov-2020

Tuesday 1-Dec-2020

Wednesday 2-Dec-2020

Thursday 3-Dec-2020

Friday 4-Dec-2020

09.00- 09.50 Lecture

Myocardium F. Özkan

Lecture Congestive Heart Failure I

A. Türer Cabbar

Lecture

Rheumatic Heart Disease A. Sav


Lecture Pathophysiology of Respiratory

System Disorders I M. Kaçar

10.00- 10.50 Lecture

Ischemic Heart Disease I F. Özkan

Lecture Congestive Heart Failure II

A. Türer Cabbar

Lecture CVS Tumors

A. Sav Independent Learning


System Disorders II M. Kaçar

11.00- 11.50 Lecture

Ischemic Heart Disease II F. Özkan

Lecture Grown-up Congenital Heart

Disease A. Türer Cabbar

Lecture Hypersensitivity reactions

G. Yanıkkaya Demirel Independent Learning


System Disorders III M. Kaçar

12.00- 12.50

Lecture Pharmacology of

ReninAngiotensin System E. N. Özdamar

Lecture Pharmacology Case Studies

E. N. Özdamar

Lecture Hypersensitivity reactions

G. Yanıkkaya Demirel Independent Learning


System Disorders IV M. Kaçar

12.50 - 14.00 LUNCH BREAK

14.00- 14.50

Lecture Pathology of Endocardium &

Heart Valves I A. Sav

Lecture History and Symptoms in

Pulmonary Diseases S. Akduman

Lecture Electrocardiography I

B. Hünük

Lecture Diagnostic Methods in Pulmonary

Medicine S. Akduman


15.00- 15.50

Lecture Pathology of Endocardium &

Heart Valves II A. Sav

Lecture Physical Examination and Signs

in Pulmonary Diseases S. Akduman

Lecture Electrocardiography II

B. Hünük

Lecture Clinical Application of Pulmonary

Function Tests S. Akduman


16.00- 16.50 Lecture

Valvular Heart Diseases O. Özveren

Lecture Chronic Obstructive Pulmonary

Disease S. Akduman

Lecture Cardiac Arrhythmias

B. Hünük

Lecture Bronchial Hyperreactivity and

Asthma S. Akduman


17.00-17.50

Lecture Infective Endocarditis and Acute

Rheumatic Fever O. Özveren

Lecture Adrenergic Receptor Blockers

E. Genç

Lecture Congenital Heart Disease in

Pediatrics T. Çoşkun

Lecture Adrenergic Neuron Blockers

E. Genç Independent Learning

8

COMMITTEE II - CARDIOVASCULAR and RESPIRATORY SYSTEMS WEEK III / 7-11 Dec 2020

Monday

7-Dec-2020 Tuesday

8-Dec-2020 Wednesday 9-Dec-2020

Thursday 10-Dec-2020

Friday 11-Dec-2020

09.00- 09.50

Lecture Diseases of the Nose and

Paranasal Sinuses A.Tatlıpınar

Lecture Pulmonary Tuberculosis

B. Salepçi

Lecture Pulmonary Infections I

F. Özkan

Lecture Ethical Issues at the Beginning of

Life E. Vatanoğlu Lutz

ICP-CSL (Advanced Cardiac Life Support)

F. Menda/ N. Kızılcık/ T. Utku

10.00- 10.50

Lecture Nasopharyngeal and

Oropharyngeal Diseases A.Tatlıpınar

Lecture Pulmonary Embolism

B. Salepçi

Lecture Pulmonary Infections II

F. Özkan

Lecture Ethical Issues in Paediatrics

E. Vatanoğlu Lutz

Gro

up

A IL

Gro

up

B IL

Gro

up

C

ICP

Gro

up

D

Sm

all G

rou

p S

tud

y

SR

PC

11.00- 11.50

Lecture Atherosclerosis &

Hypertension I A. Sav

Lecture Special Pulmonary Problems

B. Salepçi

Lecture Tracheobronchitis

B. Salepçi

Lecture Ethics in Intensive Care

E. Vatanoğlu Lutz

12.00- 12.50

Lecture Atherosclerosis & Hypertension II

A. Sav

Lecture Emergency Evaluation of Dyspnea

M. Ekşioğlu

Lecture Pneumoniae B. Salepçi

Lecture Ethics in Psychiatry E. Vatanoğlu Lutz


12.50 – 14.00 LUNCH BREAK

14.00- 14.50

Lecture Principals of Statistical

Analysis I Ç. Altunok

Lecture Laryngeal and Voice Diseases

A.Tatlıpınar

Lecture Chronic Obstructive

Pulmonary Diseases F. Özkan

Lecture Pulmonary Hypertension

B. Salepçi

ICP-CSL (Advanced Cardiac Life Support) F. Menda / N. Kızılcık / T. Utku

15.00- 15.50

Lecture Principals of Statistical

Analysis II Ç. Altunok

Lecture Diseases of the Middle Ear and

Eustachian Tube A.Tatlıpınar

Lecture Asthma Bronchiale

F. Özkan

Lecture Respiratory Failure

B. Salepçi

Gro

up

A IL

Gro

up

B IL

Gro

up

C

Sm

all G

rou

p S

tud

y

SR

PC

Gro

up

D

ICP

16.00- 16.50 Independent Learning Independent Learning

Lecture Congenital Lung Anomalies &

Atalectasis F. Özkan

Lecture Drugs Used in Cardiac

Arrythmias I E. N. Özdamar

17.00-17.50 Independent Learning Independent Learning

Lecture Pathology of Upper Respiratory Tract

F. Özkan

Lecture Drugs Used in Cardiac

Arrythmias II E. N. Özdamar


9


WEEK IV / 14-18 Dec 2020

Monday

14-Dec-2020 Tuesday



Friday 18-Dec-2020


Lecture Tumors of the Respiratory

System I A. Sav


Lecture Diuretic Agents I E. N. Özdamar


Lecture Tumors of the Respiratory

System II A. Sav

Lecture Tobacco Control and

Chronic Non-Communicable Diseases I

R.E. Sezer

Lecture Diuretic Agents II E. N. Özdamar


Lecture Drugs Used in the Treatment of

Dyslipidemias I E. N. Özdamar

Lecture Congestive Heart Failure

F. Özkan


Chronic Non-Communicable Diseases II

R.E. Sezer


Angina Pectoris E. N. Özdamar



Dyslipidemias II E. N. Özdamar

Lecture Congestive Heart Failure &

Pericardium F. Özkan


Chronic Non-Communicable Diseases III

R.E. Sezer

Lecture Anticoagulant, Antiplatelet &

Thrombolytic drugs E. N. Özdamar

12.50 – 14.00

LUNCH BREAK

14.00- 14.50

ICP-CSL (Examination of Cardiovascular and

Respiratory System) O. Özveren / M. A. Şimşek /

B. Salepçi / S. Akduman

ICP-CSL (Examination of Cardiovascular and

Respiratory System) O. Özveren / M. A. Şimşek /


Lecture Approach to the Patient with Cough and Heameoptysis in

Primary Care Ö. Tanrıöver

Lecture Pathology of Pleural and

Mediastinal Diseases A. Sav

Path

olo

gy

Lab

ora

tory

(C

ard

iovascula

r and

Respirato

ry S

yste

ms)

F.

Özkan / A

. S

av

Gro

up

B

Gro

up

A IL

15.00- 15.50

Gro

up

C

ICP

Gro

up

D

Sm

all G

rou

p S

tud

y

SR

PC

Gro

up

A IL

Gro

up

B IL

Gro

up

C

Sm

all G

rou

p S

tud

y

SR

PC

Gro

up

D

ICP

Gro

up

A IL

Gro

up

B IL

Lecture Approach to the Patient with

Dyspnea in Primary Care Ö. Tanrıöver


16.00- 16.50

Lecture Pediatric Advanced Life

Support M. Yazıcıoğlu

Introduction to Elective Courses

Gro

up

B I

L

Gro

up

A

17.00-17.50 Independent Learning Independent Learning Independent Learning Independent Learning

10

COMMITTEE II - CARDIOVASCULAR and RESPIRATORY SYSTEMS WEEK V / 21-25 Dec 2020

Monday

21-Dec-2020 Tuesday



Friday 25-Dec-2020

09.00- 09.50 Independent Learning Lecture

Bloodstream Invasion & Sepsis I M. Sönmezoğlu

ICP-CSL (Examination of Cardiovascular

and Respiratory System) O. Özveren / M. A. Şimşek /



10.00- 10.50

Lecture Respiratory Muscles and Surgical

Anatomy of Thorax S. Ercan

Lecture Bloodstream Invasion & Sepsis II

M. Sönmezoğlu

Gro

up

C IL

Gro

up

D IL

Gro

up

B

ICP

Gro

up

A

Sm

all G

rou

p S

tud

y

SR

PC


11.00- 11.50

Lecture Surgical Disorders of Mediastinum and

the Diaphragm S. Ercan

Lecture Cardiac Infections M. Sönmezoğlu


12.00- 12.50

Lecture Surgical Treatment of Pulmonary

Diseases S. Ercan

Lecture Treatment of Cough & Drugs Used in the Treatment of Common Cold

E. N. Özdamar

Independent Learning Independent Learning Independent Learning

12.50- 14.00 LUNCH BREAK

14.00- 14.50 Lecture

Preparing to Analyse Data Ç. Altunok

Lecture Drugs Used in Congestive Heart

Disease I E. N. Özdamar

Lecture Pharmacology and Toxicology of

Tobacco E. N. Özdamar


ICP-CSL (Examination of Cardiovascular

and Respiratory System) O. Özveren / M. A. Şimşek /


15.00- 15.50

Lecture Approach to Patient with Chest Pain in

Primary Care I G. İzbırak

Lecture Drugs Used in Congestive Heart

Disease II E. N. Özdamar

Lecture Drugs Used in the Treatment of Asthma & Chronic Obstructive

Lung Disease E. N. Özdamar


Gro

up

C IL

Gro

up

D IL

Gro

up

B

Sm

all G

rou

p S

tud

y

SR

PC

Gro

up

A

ICP

16.00- 16.50

Lecture Approach to Patient with Chest Pain in

Primary Care II G. İzbırak


Lecture Tobacco Control and Chronic

Non-Communicable Diseases IV R.E. Sezer


17.00-17.50 Independent Learning Independent Learning

Lecture Epidemiology, Prevention and

Control of Chronic Non-Communicable Respiratory

Diseases R.E. Sezer


11

COMMITTEE II - CARDIOVASCULAR and RESPIRATORY SYSTEMS WEEK VI / 28 Dec 2020-1 Jan 2021

Monday

28-Dec-2020 Tuesday



Friday 1-Jan-2021

09.00- 09.50 Lecture

Bronchiectasis S. Akduman

Lecture Upper and Lower Respiratory

System Infections I A.Ç. Büke

Lecture Interstitial Lung Diseases

B. Salepçi


New Year’s Day

10.00- 10.50 Lecture

Lung Cancer S. Akduman

Lecture Upper and Lower Respiratory

System Infections II A.Ç. Büke

Lecture Sleep Apnea Syndrome

B. Salepçi Independent Learning

11.00- 11.50 Lecture

Pleural Diseases S. Akduman

Lecture Inherited Respiratory System

Disorders A. Kuşkucu

Multidisciplinary Case Discussion Panel


12.00- 12.50 Lecture

X-Ray Examination of the Lungs F. Çelebi

Lecture Inherited Cardiovascular Disorders

A.Ç. Kuşkucu

Multidisciplinary Case Discussion Panel


12.50- 14.00 LUNCH BREAK

14.00- 14.50

Lecture Approach to the Pediatric Patient with

Pneumonia H. Sarıçoban


Lecture Chronic Restrictive Pulmonary

Diseases I A. Sav


New Year’s Day

15.00- 15.50

Lecture Epidemiology and Prevention of

Cardiovascular Diseases I H.A.Taşyıkan

Independent Learning Chronic Restrictive Pulmonary

Diseases II A. Sav


16.00- 16.50

Lecture Epidemiology and Prevention of

Cardiovascular Diseases II H.A.Taşyıkan


Congenital Heart Disease I A. Sav


17.00-17.50

Lecture Public Health and Chronic

Non-Communicable Diseases H.A. Taşyıkan


Congenital Heart Disease II A. Sav


12

COMMITTEE II - CARDIOVASCULAR and RESPIRATORY SYSTEMS WEEK VII / 4-8 Jan 2021

Monday

4-Jan-2021 Tuesday

5-Jan-2021 Wednesday 6-Jan-2021

Thursday 7-Jan-2021

Friday 8-Jan-2021

09.00- 09.50

Independent Learning Independent Learning Independent Learning Independent Learning


10.00- 10.50

COMMITTEE EXAM 11.00- 11.50

12.00- 12.50

13.00- 14.00 LUNCH BREAK Program Evaluation Session

Committee II Coordination Committee Members

14.00- 14.50

Independent Learning Independent Learning Independent Learning Independent Learning Independent Learning

15.00- 15.50

16.00- 16.50

17.00-17.50

Documents

COMMITTEE II - CARDIOVASCULAR & RESPIRATORY ......2 COMMITTEE II - CARDIOVASCULAR & RESPIRATORY SYSTEMS LECTURERS MED 302 INTRODUCTION to CLINICAL SCIENCES DISCIPLINE LECTURERS PHARMACOLOGY